Coagulation and fibrinolysis in gastric cancer

@article{Repetto2017CoagulationAF,
  title={Coagulation and fibrinolysis in gastric cancer},
  author={Ombretta Repetto and Valli De Re},
  journal={Annals of the New York Academy of Sciences},
  year={2017},
  volume={1404}
}
  • O. Repetto, V. Re
  • Published 1 September 2017
  • Biology, Medicine
  • Annals of the New York Academy of Sciences
Coagulation is a highly conserved process occurring after an injury to a blood vessel and resulting in hemostasis. In the thrombus microenvironment, finely orchestrated events restore vessel integrity through platelet activation, adhesion, and aggregation (primary hemostasis), followed by the coagulation cascades, thrombin generation, and fibrin clot deposition (secondary hemostasis). Several studies on cancer have provided insight into dramatic changes to coagulation‐related events (i.e… 
Platelets, Constant and Cooperative Companions of Sessile and Disseminating Tumor Cells, Crucially Contribute to the Tumor Microenvironment
TLDR
Understanding the close liaison of cancer cells with platelets and coagulation factors that change the TME during tumor progression and spreading will help to curb different steps of the metastatic cascade and may help to reduce tumor-induced thrombosis.
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
TLDR
A previously unrecognized pivotal role for immune activation in triggering disorders of the coagulation-fibrinolysis system in cancer patients during treatment with ICI is suggested.
Platelets in aging and cancer—“double-edged sword”
TLDR
The changes that occur in platelets during aging are reviewed, and how these versatile blood components contribute to cancer progression is investigated.
Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma
TLDR
The quantification of FGB and cleaved products may help to further characterize the interconnections between GC and platelet/coagulation pathways, as well as to characterize the fibrinogen β chain itself.
Parameters of hemostatic potential in various stages of bladder cancer
TLDR
A significant increase in the level of fibrin, fibr inogen, and PAI-1 is investigated, depending on the degree of bladder cancer, to find molecular and biochemical predictive parameters that would be characterized by high specificity and sensitivity to the tumor development.
C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients
TLDR
Complement 8 beta chain (C8B) in the complement and coagulation cascades signaling pathway serves as a predictive candidate for survival in HBV-related HCC patients.
A Comprehensive Review of Congenital Platelet Disorders, Thrombocytopenias and Thrombocytopathies
TLDR
A detailed literature review of rare thrombocytopathies, including disorders of adhesion like von Willebrand's disease or Bernard-Soulier syndrome, are reviewed.
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
TLDR
The role of various miRNAs and their targets in tumor angiogenesis are discussed, the strategies and challenges of miRNA-based anti-angiogenic therapies are described, and the potential use ofmiRNAs as biomarkers for anti-ANGiogenic therapy response is explored.
Development and Validation of a Practical Prognostic Coagulation Index for Patients with Esophageal Squamous Cell Cancer
TLDR
Multivariate analysis indicated that the Coagulation Index remained a significant factor for predicting OS, independently of pathological TNM stage, and is an independent predictor of survival for patients with ESCC.
Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer
TLDR
The data suggests that fibrinogen gamma (FGG) may be a potential therapeutic target and prognostic marker for CRPC.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 195 REFERENCES
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
TLDR
This mini-review will update the mechanisms of thrombosis and the current state of antiplatelet therapies, and will focus on platelet adhesion molecules and the novel anti-thrombotic therapies that target them.
Contribution of the hemostatic system to angiogenesis in cancer.
TLDR
These considerations support the judicious use of anticoagulants in patients with malignancy as well as encourage the search for novel antiangiogenic activities that may reside within molecular and cellular components of the hemostatic system.
Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.
TLDR
Results demonstrate tumor cell-associated TF-dependent extravascular coagulation activation in situ in gastric cancer that does not appear to be counterbalanced by TFPI or sufficient fibrinolytic activity.
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
TLDR
Understanding how the extrinsic pathway of blood coagulation contributes to hemostasis and thrombosis may lead to the development of safe and effective hemostatic agents and antithrombotic drugs.
The role of hemostatic system inhibitors in malignancy.
TLDR
This review summarizes up-to-date information on preclinical and clinical benefits and pitfalls of hemostatic system inhibitors administration in cancer, with special emphasis on tumor biology and prophylaxis and treatment of various complications observed in the course of malignant disease.
Tissue Factor, Blood Coagulation, and Beyond: An Overview
  • A. Chu
  • Medicine
    International journal of inflammation
  • 2011
TLDR
TF suppression, anticoagulation, PAR blockade, or general anti-inflammation offers an array of therapeutical benefits for easing diverse pathological conditions.
Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.
TLDR
The role of TF in tumour biology and cancer-associated VTE is focused on and pharmacological inhibition of the TF pathway in selective tumour types and patient subgroups would be in line with the modern concept of individualized, targeted anti-cancer therapy.
The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
TLDR
The role of fibrinogen and the products of its degradation in the progression of various tumors is not sufficiently understood.
Coagulation and non‐coagulation effects of thrombin
TLDR
The hemostatic and non‐hemostatic dual role of thrombin under various conditions and in relation to cardiovascular disease are highlighted, and the exact mechanism behind the dichotomy ofThrombin is still unknown.
Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo
TLDR
This review summarizes knowledge gained with in vivo imaging techniques in animal models that provides new insights into the spatiotemporal regulation of coagulation and platelet activation at a site of vascular injury.
...
1
2
3
4
5
...